Presentations
POSTER
Controlling intracellular cortisol: Can HSD-1 inhibition reduce Cushing’s syndrome morbidity and minimize adrenal insufficiency risk?
POSTER
HPA axis modulation by a potent inhibitor indicates 11b-hydroxysteroid dehydrogenase type 1 (HSD-1) is a significant contributor to cortisol levels
POSTER
The “RESCUE” Trial: 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Inhibition
for ACTH-Dependent Cushing’s Syndrome
POSTER